U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Rifampin - Oral, Injection products
  1. Development Resources

Rifampin - Oral, Injection products

Exceptions or additions to the recognized standards

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Staphylococcus spp.

Enterococcus spp.

Haemophilus influenzae and Haemophilus parainfluenzae

Streptococcus pneumoniae

HACEK group: Haemophilus spp., Aggregatibacter spp., Cardiobacterium hominis, Eikenella corrodens and Kingella spp.

Moraxella catarrhalis

Back to Top